Farmers & Merchants Investments Inc. Sells 8,931 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Farmers & Merchants Investments Inc. lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 43.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,436 shares of the pharmacy operator’s stock after selling 8,931 shares during the period. Farmers & Merchants Investments Inc.’s holdings in Walgreens Boots Alliance were worth $107,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Cidel Asset Management Inc. grew its holdings in Walgreens Boots Alliance by 29.8% in the fourth quarter. Cidel Asset Management Inc. now owns 61,847 shares of the pharmacy operator’s stock worth $577,000 after purchasing an additional 14,191 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in Walgreens Boots Alliance by 2.9% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 68,942 shares of the pharmacy operator’s stock worth $643,000 after acquiring an additional 1,926 shares in the last quarter. Silver Oak Securities Incorporated purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $110,000. Finally, Centennial Wealth Advisory LLC raised its position in shares of Walgreens Boots Alliance by 44.6% in the 4th quarter. Centennial Wealth Advisory LLC now owns 24,750 shares of the pharmacy operator’s stock valued at $231,000 after purchasing an additional 7,637 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Up 0.7 %

Walgreens Boots Alliance stock opened at $10.12 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company’s fifty day moving average price is $10.22 and its 200 day moving average price is $9.82. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.96.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the company earned $0.66 earnings per share. The company’s quarterly revenue was up 7.6% on a year-over-year basis. On average, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Jefferies Financial Group decreased their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Evercore ISI boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Truist Financial reduced their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Bank of America increased their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Finally, TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $13.19.

View Our Latest Stock Report on Walgreens Boots Alliance

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.